Series B funding round for Arkuda Therapeutics raising $64M in February 2022
Series B funding round for Arkuda Therapeutics raising $64M in February 2022
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Eli Lilly | |
| Angel | Brandon Capital Partners |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$108M
Top Valuation
-
Arkuda Therapeutics raised $64M in a Series B round.
The round was announced on 02/01/22.
The round was led by Pivotal bioVenture Partners, Raymond Kelleher.